ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 51 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,930,000 | -44.3% | 3,000,000 | 0.0% | 1.78% | -39.5% |
| Q2 2023 | $28,590,000 | +86536.4% | 3,000,000 | 0.0% | 2.94% | -28.6% |
| Q1 2023 | $33,000 | -25.7% | 3,000,000 | 0.0% | 4.12% | -16.9% |
| Q4 2022 | $44,400 | -99.9% | 3,000,000 | 0.0% | 4.96% | -27.5% |
| Q3 2022 | $57,330,000 | -10.3% | 3,000,000 | 0.0% | 6.84% | -8.7% |
| Q2 2022 | $63,930,000 | -16.6% | 3,000,000 | -24.6% | 7.50% | +0.7% |
| Q1 2022 | $76,641,000 | -7.1% | 3,979,292 | 0.0% | 7.44% | +13.7% |
| Q4 2021 | $82,531,000 | -13.2% | 3,979,292 | 0.0% | 6.54% | +11.0% |
| Q3 2021 | $95,065,000 | -12.5% | 3,979,292 | 0.0% | 5.90% | -17.1% |
| Q2 2021 | $108,595,000 | -5.7% | 3,979,292 | 0.0% | 7.12% | +9.1% |
| Q1 2021 | $115,121,000 | +2.8% | 3,979,292 | 0.0% | 6.52% | -7.2% |
| Q4 2020 | $111,937,000 | -4.0% | 3,979,292 | 0.0% | 7.03% | -35.3% |
| Q3 2020 | $116,593,000 | -3.1% | 3,979,292 | 0.0% | 10.87% | -13.8% |
| Q2 2020 | $120,334,000 | +1.5% | 3,979,292 | 0.0% | 12.60% | -37.2% |
| Q1 2020 | $118,583,000 | – | 3,979,292 | – | 20.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $296,569,000 | 22.84% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $111,937,000 | 7.03% |
| Pivotal bioVenture Partners Investment Advisor LLC | 671,716 | $18,895,000 | 6.23% |
| Omega Fund Management, LLC | 640,199 | $18,009,000 | 2.70% |
| Orbimed Advisors | 6,073,850 | $170,857,000 | 1.50% |
| Vivo Capital, LLC | 867,170 | $24,393,000 | 1.09% |
| Octagon Capital Advisors LP | 100,000 | $2,813,000 | 0.98% |
| Altium Capital Management LP | 62,962 | $1,771,000 | 0.66% |
| RA Capital Management | 1,165,184 | $32,777,000 | 0.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 8,505 | $239,000 | 0.14% |